Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Breast Cancer Res Treat. 2016 Oct 3;160(2):291–296. doi: 10.1007/s10549-016-4005-7

Table 3.

Proportion of radiation omission with exact 95% confidence intervals, overall and by year of screening and age.

All patients Patients who received ET Patients aged 70–74 Patients aged 75 or older
All years 36.8 [28, 46.2] 35.5 [24.9, 47.3] 24.1 [13.9, 37.2] 49.2 [35.9, 62.5]
2009 54.5 [32.2, 75.6] 55.6 [21.2, 86.3] 54.5 [23.4, 83.3] 54.5 [23.4, 83.3]
2010 47.4 [24.4, 71.1] 40 [16.3, 67.7] 16.7 [0.4, 64.1] 61.5 [31.6, 86.1]
2011 41.2 [18.4, 67.1] 66.7 [29.9, 92.5] 30 [6.7, 65.2] 57.1 [18.4, 90.1]
2012 25.9 [11.1, 46.3] 25 [8.7, 49.1] 11.8 [1.5, 36.4] 50 [18.7, 81.3]
2013 7.7 [0.2, 36] 9.1 [0.2, 41.3] 0 [0, 52.2] 12.5 [0.3, 52.7]
2014 36.8 [16.3, 61.6] 33.3 [9.9, 65.1] 22.2 [2.8, 60] 50 [18.7, 81.3]

ET: endocrine therapy